Patients with acne appeared to have an increasing risk of suicide albeit one that was not statistically significant three years before isotretinoin treatment started, which lasted through six months post-treatment, according to Anders Sundstrom, PhD, of the Karolinska Institute in Stockholm, and colleagues.
They reported online in BMJ that the finding “motivates a close monitoring of patients for suicidal behaviour for up to a year after treatment has ended.”
However, they noted that patients with a history of suicide attempts before isotretinoin treatment made new attempts to a lesser extent than did those who started such behaviour in connection with treatment.
Read more.
Tags: Dermatology
